Ptolemaios G Sarrigiannis

Ptolemaios G Sarrigiannis

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2021 in Human Brain Mapping
Verified
Journal Article
Open access
PDF file
JCJUN CAO
JUN CAO
Yifan ZhaoYifan Zhao
Yifan Zhao
XSXiaocai Shan
Xiaocai Shan
Hua-Liang WeiHua-Liang Wei
Hua-Liang Wei
Yuzhu GuoYuzhu Guo
Yuzhu Guo
PSPtolemaios G Sarrigiannis
Ptolemaios G Sarrigiannis
Functional connectivity and effective connectivity of the human brain, representing statistical dependence and directed information flow between cortical regions, significantly contribute to the study of the intrinsic brain network and its functional mechanism. Many recent studies on electroencephalography (EEG) have been focusing on modeling and estimating brain connectivity due to increasing evidence that it can help better understand various brain neurological conditions. However, there is a lack of a comprehensive updated review on studies of EEG‐based brain connectivity, particularly on visualization options and associated machine learning applications, aiming to translate those techniques into useful clinical tools. This article reviews EEG‐based functional and effective connectivity studies undertaken over the last few years, in terms of estimation, visualization, and applications associated with machine learning classifiers. Methods are explored and discussed from various dimensions, such as either linear or nonlinear, parametric or nonparametric, time‐based, and frequency‐based or time‐frequency‐based. Then it is followed by a novel review of brain connectivity visualization methods, grouped by Heat Map, data statistics, and Head Map, aiming to explore the variation of connectivity across different brain regions. Finally, the current challenges of related research and a roadmap for future related research are presented.

25 June 2022 in Human Brain Mapping
Verified
Journal Article
Open access
XSXiaocai Shan
Xiaocai Shan
JCJUN CAO
JUN CAO
Shoudong HuoShoudong Huo
Shoudong Huo
LCLiangyu Chen
Liangyu Chen
PSPtolemaios G Sarrigiannis
Ptolemaios G Sarrigiannis
Yifan ZhaoYifan Zhao
Yifan Zhao
Functional connectivity of the human brain, representing statistical dependence of information flow between cortical regions, significantly contributes to the study of the intrinsic brain network and its functional mechanism. To fully explore its potential in the early diagnosis of Alzheimer's disease (AD) using electroencephalogram (EEG) recordings, this article introduces a novel dynamical spatial–temporal graph convolutional neural network (ST‐GCN) for better classification performance. Different from existing studies that are based on either topological brain function characteristics or temporal features of EEG, the proposed ST‐GCN considers both the adjacency matrix of functional connectivity from multiple EEG channels and corresponding dynamics of signal EEG channel simultaneously. Different from the traditional graph convolutional neural networks, the proposed ST‐GCN makes full use of the constrained spatial topology of functional connectivity and the discriminative dynamic temporal information represented by the 1D convolution. We conducted extensive experiments on the clinical EEG data set of AD patients and Healthy Controls. The results demonstrate that the proposed method achieves better classification performance (92.3%) than the state‐of‐the‐art methods. This approach can not only help diagnose AD but also better understand the effect of normal ageing on brain network characteristics before we can accurately diagnose the condition based on resting‐state EEG.

23 March 2022 in Pain and Therapy
Verified
Journal Article
Open access
PDF file
Panagiotis ZisPanagiotis Zis
Panagiotis Zis
LALiampas Andreas
Liampas Andreas
Artemios ArtemiadisArtemios Artemiadis
Artemios Artemiadis
GTGabriela Tsalamandri
Gabriela Tsalamandri
PNPanagiota Neophytou
Panagiota Neophytou
PSPtolemaios G Sarrigiannis
Ptolemaios G Sarrigiannis
Introduction The universality and complexity of pain, which is highly prevalent, yield its significance to both patients and researchers. Developing a non-invasive tool that can objectively measure pain is of the utmost importance for clinical and research purposes. Traditionally electroencephalography (EEG) has been mostly used in epilepsy; however, over the recent years EEG has become an important non-invasive clinical tool that has helped increase our understanding of brain network complexities and for the identification of areas of dysfunction. This review aimed to investigate the role of EEG recordings as potential biomarkers of pain perception. Methods A systematic search of the PubMed database led to the identification of 938 papers, of which 919 were excluded as a result of not meeting the eligibility criteria, and one article was identified through screening of the reference lists of the 19 eligible studies. Ultimately, 20 papers were included in this systematic review. Results Changes of the cortical activation have potential, though the described changes are not always consistent. The most consistent finding is the increase in the delta and gamma power activity. Only a limited number of studies have looked into brain networks encoding pain perception. Conclusion Although no robust EEG biomarkers of pain perception have been identified yet, EEG has potential and future research should be attempted. Designing strong research protocols, controlling for potential risk of biases, as well as investigating brain networks rather than isolated cortical changes will be crucial in this attempt.

26 February 2020 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
MMMarie-Louise Mallet
Marie-Louise Mallet
Marios HadjivassiliouMarios Hadjivassiliou
Marios Hadjivassiliou
PSPtolemaios G Sarrigiannis
Ptolemaios G Sarrigiannis
Panagiotis ZisPanagiotis Zis
Panagiotis Zis

1 September 2014 in Cerebellum & Ataxias
Verified
Journal Article
Open access
PDF file
PSPtolemaios G Sarrigiannis
Ptolemaios G Sarrigiannis
NHNigel Hoggard
Nigel Hoggard
DADaniel Aeschlimann
Daniel Aeschlimann
DSDavid S Sanders
David S Sanders
RGRichard A Grünewald
Richard A Grünewald
Marios HadjivassiliouMarios Hadjivassiliou
Marios Hadjivassiliou
Cortical myoclonus with ataxia has only rarely been reported in association with Coeliac Disease (CD). Such reports also suggested that it is unresponsive to gluten-free diet. We present detailed electro-clinical characteristics of a new syndrome of progressive cortical hyperexcitability with ataxia and refractory CD. At our gluten/neurology clinic we have assessed and regularly follow up over 600 patients with neurological manifestations due to gluten sensitivity. We have identified 9 patients with this syndrome. All 9 patients (6 male, 3 female) experienced asymmetrical irregular myoclonus involving one or more limbs and sometimes face. This was often stimulus sensitive and became more widespread over time. Three patients had a history of Jacksonian march and five had at least one secondarily generalised seizure. Electrophysiology showed evidence of cortical myoclonus. Three had a phenotype of epilepsia partialis continua at onset. There was clinical, imaging and/or pathological evidence of cerebellar involvement in all cases. All patients adhered to a strict gluten-free diet with elimination of gluten-related antibodies in most. However, there was still evidence of enteropathy in all, suggestive of refractory celiac disease. Two died from enteropathy-associated lymphoma and one from status epilepticus. Five patients were treated with mycophenolate and one in addition with rituximab and IV immunoglobulins. Their ataxia and enteropathy improved but myoclonus remained the most disabling feature of their illness. This syndrome may well be the commonest neurological manifestation of refractory CD. The clinical involvement, apart from ataxia, covers the whole clinical spectrum of cortical myoclonus.

17 July 2018 in Brain Sciences
Verified
Journal Article
Open access
PDF file
DBDaniel Blackburn
Daniel Blackburn
Yifan ZhaoYifan Zhao
Yifan Zhao
MMMatteo De Marco
Matteo De Marco
SBSimon Bell
Simon Bell
FHFei He
Fei He
PSPtolemaios G Sarrigiannis
Ptolemaios G Sarrigiannis
Background: The incidence of Alzheimer disease (AD) is increasing with the ageing population. The development of low cost non-invasive diagnostic aids for AD is a research priority. This pilot study investigated whether an approach based on a novel dynamic quantitative parametric EEG method could detect abnormalities in people with AD. Methods: 20 patients with probable AD, 20 matched healthy controls (HC) and 4 patients with probable fronto temporal dementia (FTD) were included. All had detailed neuropsychology along with structural, resting state fMRI and EEG. EEG data were analyzed using the Error Reduction Ratio-causality (ERR-causality) test that can capture both linear and nonlinear interactions between different EEG recording areas. The 95% confidence intervals of EEG levels of bi-centroparietal synchronization were estimated for eyes open (EO) and eyes closed (EC) states. Results: In the EC state, AD patients and HC had very similar levels of bi-centro parietal synchronization; but in the EO resting state, patients with AD had significantly higher levels of synchronization (AD = 0.44; interquartile range (IQR) 0.41 vs. HC = 0.15; IQR 0.17, p < 0.0001). The EO/EC synchronization ratio, a measure of the dynamic changes between the two states, also showed significant differences between these two groups (AD ratio 0.78 versus HC ratio 0.37 p < 0.0001). EO synchronization was also significantly different between AD and FTD (FTD = 0.075; IQR 0.03, p < 0.0001). However, the EO/EC ratio was not informative in the FTD group due to very low levels of synchronization in both states (EO and EC). Conclusion: In this pilot work, resting state quantitative EEG shows significant differences between healthy controls and patients with AD. This approach has the potential to develop into a useful non-invasive and economical diagnostic aid in AD.